Plasmapheresis for Thrombotic Thrombocytopenic Purpura following Bone Marrow Transplantation

Kolker; Sviri; Linton; Or; Nagler; Shapira
April 2001
Acta Haematologica;2001, Vol. 105 Issue 3, p156
Academic Journal
Recognition of thrombotic thrombocytopenic purpura (TTP)/hemolytic uremic syndrome (HUS) following bone marrow transplantation (BMT) has increased in recent years. The use of plasma exchange has greatly improved the outlook of de novo TTP. Fewer data are available on its use in post-BMT TTP but small uncontrolled series showed poor results with low response rates. We present here a case of a young patient who developed manifestations of TTP 10 months after BMT with complete recovery following treatment with plasma exchange for 1 month. This case suggests that plasma exchange could be life saving and should be tried in every patient with post-BMT TTP.Copyright © 2001 S. Karger AG, Basel


Related Articles

  • Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Iacopino, P; Pucci, G; Arcese, W; Bosi, A; Falda, M; Locatelli, F; Marenco, P; Miniero, R; Morabito, F; Rossetti, F; Sica, S; Uderzo, C; Bacigalupo, A // Bone Marrow Transplantation;7/1/99, Vol. 24 Issue 1, p47 

    Thrombotic microangiopathy (TMA) usually occurs during the first weeks following transplantation in the setting of systemic infections or graft-versus-host reaction. However, some cases without any evidence of other complications or after autologous transplantation have been reported....

  • Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Paquette, R L; Tran, L; Landaw, E M // Bone Marrow Transplantation;8/15/98, Vol. 22 Issue 4, p351 

    Thrombotic microangiopathy (TM), manifesting clinically as thrombotic thrombocytopenic purpura or hemolytic uremic syndrome, is an uncommon complication after bone marrow transplantation (BMT). A retrospective analysis of potential risk factors for TM following allogeneic BMT was performed....

  • Thrombotic Microangiopathy in the Cancer Patient. Kwaan, Hau C.; Gordon, Leo I. // Acta Haematologica;2001, Vol. 106 Issue 1/2, p52 

    Thrombotic microangiopathy, manifesting as thrombotic thrombocytopenic purpura (TTP) or hemolytic uremic syndrome, is a common complication in cancer patients. It shares the pathogenic microvascular occlusive lesion and many clinical manifestations as the classical TTP, but the spectrum of...

  • Utility of ADAMTS13 Assays in Diagnosing Thrombotic Thrombocytopenic Purpura... In Reply. Barrows, Brad D.; Teruya, Jun // Archives of Pathology & Laboratory Medicine;Apr2015, Vol. 139 Issue 4, p433 

    A response from the author of the article "Use of the ADAMTS13 activity assay improved the accuracy and efficiency of the diagnosis and treatment of suspected acquired thrombotic thrombocytopenic purpura" by Brad D. Barrows and Jun Teruya in the 2014 issue is presented.

  • Disseminated Malignancy Misdiagnosed as Thrombotic Thrombocytopenic Purpura: A Report of 10 Patients and a Systematic Review of Published Cases. Francis, Kristin K.; Kalyanam, Nalini; Terreli, Deirdra R.; Vesely, Sara K.; George, James N. // Oncologist;Jan2007, Vol. 12 Issue 1, p11 

    Background. Patients with disseminated malignancy who present with microangiopathic hemolytic anemia and thrombocytopenia may be misdiagnosed as thrombotic thrombocytopenic purpura (TTP), resulting in inappropriate plasma exchange treatment, a procedure with major risk, and delay of appropriate...

  • Clinical experience in treatment of thrombotic thrombocytopenic purpura - hemolytic uremic syndrome with 28 patients. Vučelić, Dragica; Rajić, Zoran; Savić, Nebojša; Miković, Danijela; Budišin, Živko; Antonijević, Nebojša M.; Obradović, Slobodan; Jevtić, Dragana; Bettoni, Giuseppe; Casoli, Gloria; Peyvandi, Flora // Acta Chirurgica Iugoslavica;2013, Vol. 60 Issue 1, p29 

    Background: Neither optimal treatment nor significance of ADAMTS13 (A Desintegrin And Metalloprotease with ThromboSpondin type 1 repeats) activity for diagnosis and therapy of thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) have not been defined yet. The aim of the...

  • Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder. George, J. N. // Bone Marrow Transplantation;Jun2008, Vol. 41 Issue 11, p917 

    The author reflects on the importance of hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA). He remarks that TA-TMA's importance is documented not only by the experience of clinicians but also by extensive clinical investigation. He asserts that despite...

  • Hemolytic uremic syndrome following autologous peripheral blood stem cell transplantation in a patient with malignant lymphoma. Ohno, E; Ohtsuka, E; Iwashita, T; Uno, N; Ogata, M; Kikuchi, H; Nasu, M // Bone Marrow Transplantation;5/1/97, Vol. 19 Issue 10, p1045 

    Hemolytic uremic syndrome (HUS) has been reported in patients receiving bone marrow transplantation. However, only a few cases of HUS following autologous peripheral blood stem cell transplantation (PBSCT) have been reported. We present a case of HUS developing after autologous PBSCT in a...

  • Are HUS and TTP genetically determined? Noris, Marina; Remuzzi, Giuseppi // Kidney International;Apr1998, Vol. 53 Issue 4, p1085 

    Editorial. Discusses hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Definition of the disease; Presentation of thrombotic microangiopathy in both ailments; Characteristics of the syndromes.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics